2013
DOI: 10.1097/yct.0b013e3182843866
|View full text |Cite
|
Sign up to set email alerts
|

Once- to Twice-Daily, 3-Year Domiciliary Maintenance Transcranial Direct Current Stimulation for Severe, Disabling, Clozapine-Refractory Continuous Auditory Hallucinations in Schizophrenia

Abstract: This is the first report in literature of the safe and effective use of daily to twice-daily, domiciliary, 30-min, 1- to 3-mA tDCS sessions across nearly 3 years for the treatment of continuous, disabling, clozapine-refractory auditory hallucinations in schizophrenia. Key learning points emerging from this case are presented and discussed.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
74
0
2

Year Published

2013
2013
2021
2021

Publication Types

Select...
4
3
1

Relationship

1
7

Authors

Journals

citations
Cited by 82 publications
(77 citation statements)
references
References 0 publications
1
74
0
2
Order By: Relevance
“…The treatment gains were apparent by the end of the 5-day tDCS course and were maintained for 3 months. 35 Patients in the case reports 18,31,[33][34][35] showed substantial response to tDCS, whereas those in the RCT 36 showed attenuation of hallucination ratings by only about a third. There are 2 likely explanations for the modest improvement recorded in the RCT.…”
Section: What Does the Evidence Show?mentioning
confidence: 99%
See 2 more Smart Citations
“…The treatment gains were apparent by the end of the 5-day tDCS course and were maintained for 3 months. 35 Patients in the case reports 18,31,[33][34][35] showed substantial response to tDCS, whereas those in the RCT 36 showed attenuation of hallucination ratings by only about a third. There are 2 likely explanations for the modest improvement recorded in the RCT.…”
Section: What Does the Evidence Show?mentioning
confidence: 99%
“…Only 1 report 18 has described long-term use of tDCS. In this report, a 24-year-old woman with schizophrenia had severe, antipsychotic-and clozapine-refractory, continuous, psychosocially and cognitively disabling auditory hallucinations that left her almost vegetative.…”
Section: What Does the Evidence Show?mentioning
confidence: 99%
See 1 more Smart Citation
“…In neuropsychiatric disorders, non-invasive brain stimulation methods have become increasingly popular given their targeted approach, minimal side effects, and limited drug interactions. Currently, there are no FDA-approved neuromodulation systems for the treatment of schizophrenia [59][60][61][62][63][64]. Off-label use of approved devices, however, has demonstrated promising results, especially in treating the positive symptoms of schizophrenia.…”
Section: Neuromodulationmentioning
confidence: 99%
“…The comparison shows the changes that occur during normal ageing, including the reduction in brain volume and concomitant increase in cerebrospinal fluid, which is especially obvious in the anterior (LVA) and posterior (LVP) parts of the lateral ventricle, the thinning of the bone of the skull and the reduction in white matter scientific attempts that have used brain stimulation in the person's home. TMS would be impractical for this use, but two studies have used tDCS with reasonable success (Andrade 2013;Hagenacker et al 2014). In a less controlled environment, the so-called DIY-tDCS movement has seen people construct and use tDCS devices in their own home.…”
Section: Key Unknowns and Future Directionsmentioning
confidence: 99%